ARTICLES & NEWS :Research studies

Recent research suggests complex lipid imbalances may be an underlying biological component of ADHD. VAYA Pharma's Director of Scientific Affairs Dr. Gali Artzi guest blogs in ADDitude magazine to […]

New Retrospective Study to be Presented at The American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting January 13-15, 2017 in Washington DC BALTIMORE, Jan. 10, 2017 (GLOBE […]

According to a new retrospective study conducted at Texas Child Neurology and Children's Health Services, children diagnosed with attention deficit hyperactivity disorder (ADHD) who took the medical f […]

National VAYA™ Pharma Survey Reveals Drug Holidays are Mostly Prompted by Physicians and the Desire to Reduce Medication Side Effects BALTIMORE, MARYLAND – May 4, 2016 – Approximately 6.4 mil […]

Nearly a Third of Children Who Experienced a Benefit While Taking PS-Omega-3 Were Also Able to Reduce Their ADHD Medication Dose BALTIMORE, MARYLAND – April 26, 2016 – According to a new retros […]

PS-Omega-3 is Enzymotec's Lipid Composition for Cognitive Functioning MIGDAL HA'EMEQ, ISRAEL, March 16, 2016 (GLOBENEWSWIRE) - Enzymotec Ltd., (NASDAQ:ENZY) (“Company” or "Enzymotec"), a devel […]

MIGDAL HA'EMEQ, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based nutrit […]

MIGDAL HA'EMEQ, Israel, July 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based nutrit […]

MIGDAL HA'EMEQ, Israel, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today repor […]

MIGDAL HA'EMEQ, Israel, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced the initiation of a […]

You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries.

I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site.